by Tony Dammicci | Oct 17, 2023 | Press Releases
Non-Dilutive Funding and Resources Provided to De-Risk Investment and Accelerate Commercialization October 17, 2023 10:00 ET| Source: Invizyne Technologies, Inc. Monrovia, CA, Oct. 17, 2023 (GLOBE NEWSWIRE) — Invizyne Technologies, Inc., a leading designer of...
by Tony Dammicci | Oct 11, 2023 | Press Releases
Funding Supports Project to Optimize and Scale Up Isobutanol Production to Address Potential $27.4 Billion Sustainable Aviation Fuel Market October 11, 2023 11:10 ET| Source: Invizyne Technologies, Inc. Monrovia, CA, Oct. 11, 2023 (GLOBE NEWSWIRE) — Invizyne...
by Tony Dammicci | Sep 20, 2023 | Press Releases
Shares to Begin Trading on NASDAQ on September 21, 2023 Under the Ticker Symbol “MDBH” ADDISON, TX / ACCESSWIRE / September 20, 2023 / MDB Capital Holdings, LLC, (NASDAQ:MDBH) (“MDB”), a public venture platform with the objective of growing the...
by Tony Dammicci | Sep 8, 2023 | Press Releases
The presentation included herein is a free writing prospectus and is an offer to purchase Class A Common Shares of MDB Capital Holdings, LLC (the ”Company”) in a public offering of securities of the Company. The Company has filed with the Securities and Exchange...
by Tony Dammicci | Aug 7, 2023 | Press Releases
The presentation included herein is a free writing prospectus and is an offer to purchase Class A Common Shares of MDB Capital Holdings, LLC (the ”Company”) in a public offering of securities of the Company. The Company has filed with the Securities and Exchange...
by Tony Dammicci | Mar 15, 2023 | Press Releases
Paris and Red Bank, N.J. March 13, 2023 Sanofi and Provention Bio, Inc., a U.S.-based, publicly traded biopharmaceutical company focused on intercepting and preventing immune-mediated diseases including type 1 diabetes (T1D), have entered into an agreement under...
Recent Comments